The Business Times
SUBSCRIBERS

SGX queries Biolidics on timing of disclosure that authorities had approved its Covid-19 test kits

Medical technology firm says it made disclosure after it was certain kits could be commercialised

    Published Fri, Apr 10, 2020 · 09:50 PM

    Singapore

    BIOLIDICS Ltd believes that it only became material to disclose that the firm had received approval for its virus test kits from Singapore's Health Sciences Authority (HSA) after it was certain that the kits could be commercialised.

    In an exchange filing on Thursday, the firm also said it only received approval for the product to be manufactured and marketed under its own brand some time later.

    Covid-19

    Copyright SPH Media. All rights reserved.

    Reuse this contentFeedback
    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More